CinRx Pharma Announces First Participant Dosed in CinDome’s Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
